
Computational Pathology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type
Description
Computational Pathology Market Summary
The Computational Pathology market leverages AI and digital imaging to enhance diagnostic accuracy, achieving 95% sensitivity in cancer detection. This sector is defined by its use of whole-slide imaging (WSI), machine learning for pattern recognition, and integration with EHR systems. Key features include automated tumor grading, reducing pathologists’ workload by 30%, and cloud-based platforms for remote analysis. The market supports hospitals and biotech firms, analyzing over 1M slides annually. Innovations like deep learning for biomarker detection and blockchain for data security drive adoption. The global Computational Pathology market is estimated to reach a valuation of approximately USD 400–800 million in 2025, with compound annual growth rates projected in the range of 7.0%–13.0% through 2030. Growth is fueled by rising cancer prevalence, digital pathology adoption, and AI advancements, positioning computational pathology as a transformative diagnostic tool.
Application Analysis and Market Segmentation
Hospitals & Diagnostic LabsHospitals and labs use WSI for cancer diagnostics, growing at 8%–13%, with AI reducing diagnosis time by 25%. Trends include telepathology for remote consults.
Biotechnology & Pharmaceutical CompaniesBiotech firms leverage AI for drug discovery, growing at 7.5%–12.5%, with 90% accuracy in biomarker analysis.
Academic & Research InstitutesResearch institutes, developing AI algorithms, grow at 7%–12%, with open-source platforms gaining traction.
OthersReference labs grow at 6.5%–11.5%, with cloud-based analytics.
By Component
SoftwareAI pathology software grows at 8%–13%, with deep learning improving specificity by 20%.
ServicesConsulting and integration services grow at 7%–12%, with remote training reducing costs by 15%.
Regional Market Distribution and Geographic Trends
Asia-Pacific: 8%–13% growth, with China’s cancer diagnostics and Japan’s AI research.
North America: 7.5%–12.5% growth, with U.S. hospital networks and Canada’s research hubs.
Europe: 7%–12% growth, with Germany’s digital labs and UK’s NHS integrations.
Latin America: 7.5%–12.5% growth, with Brazil’s oncology centers and Mexico’s diagnostics.
Middle East & Africa: 7%–12% growth, with UAE’s healthcare tech and South Africa’s cancer programs.
Key Market Players and Competitive Landscape
Paige.AI: AI-driven diagnostics, $200M funding.
PathAI: Cancer detection algorithms, 15% YoY growth.
Proscia: Cloud-based WSI, 10% market share.
Ibex Medical Analytics: Breast cancer diagnostics leader.
Aiforia: EU-focused AI platforms.
Visiopharm: Image analysis software.
Akoya Biosciences: Biomarker discovery, $150M revenue.
Industry Value Chain AnalysisThe value chain spans algorithm development, imaging, and diagnostic integration.
Raw Materials and Upstream SupplyWSI scanners and cloud servers, with Paige.AI securing 1,000 units annually.
Production and ProcessingAI models process 10,000 slides daily, with PathAI scaling operations.
Distribution and LogisticsCloud delivery ensures 99% uptime.
Downstream Processing and Application Integration
Hospitals: AI diagnostics.
Biotech: Biomarker analysis.Downstream yields 25% margins via automation.
End-User IndustriesLabs capture value through 95% diagnostic accuracy.
Market Opportunities and Challenges
OpportunitiesAsia-Pacific’s cancer rise drives AI adoption. Europe’s digital labs boost growth, while Latin America’s oncology expands. Cloud and telepathology enhance scalability, and biomarker niches grow.
ChallengesHigh costs—$500K per system—limit adoption. Regulatory delays slow approvals by 12 months. Data privacy risks 10% trust erosion, while pathologist training gaps impact integration.
The Computational Pathology market leverages AI and digital imaging to enhance diagnostic accuracy, achieving 95% sensitivity in cancer detection. This sector is defined by its use of whole-slide imaging (WSI), machine learning for pattern recognition, and integration with EHR systems. Key features include automated tumor grading, reducing pathologists’ workload by 30%, and cloud-based platforms for remote analysis. The market supports hospitals and biotech firms, analyzing over 1M slides annually. Innovations like deep learning for biomarker detection and blockchain for data security drive adoption. The global Computational Pathology market is estimated to reach a valuation of approximately USD 400–800 million in 2025, with compound annual growth rates projected in the range of 7.0%–13.0% through 2030. Growth is fueled by rising cancer prevalence, digital pathology adoption, and AI advancements, positioning computational pathology as a transformative diagnostic tool.
Application Analysis and Market Segmentation
Hospitals & Diagnostic LabsHospitals and labs use WSI for cancer diagnostics, growing at 8%–13%, with AI reducing diagnosis time by 25%. Trends include telepathology for remote consults.
Biotechnology & Pharmaceutical CompaniesBiotech firms leverage AI for drug discovery, growing at 7.5%–12.5%, with 90% accuracy in biomarker analysis.
Academic & Research InstitutesResearch institutes, developing AI algorithms, grow at 7%–12%, with open-source platforms gaining traction.
OthersReference labs grow at 6.5%–11.5%, with cloud-based analytics.
By Component
SoftwareAI pathology software grows at 8%–13%, with deep learning improving specificity by 20%.
ServicesConsulting and integration services grow at 7%–12%, with remote training reducing costs by 15%.
Regional Market Distribution and Geographic Trends
Asia-Pacific: 8%–13% growth, with China’s cancer diagnostics and Japan’s AI research.
North America: 7.5%–12.5% growth, with U.S. hospital networks and Canada’s research hubs.
Europe: 7%–12% growth, with Germany’s digital labs and UK’s NHS integrations.
Latin America: 7.5%–12.5% growth, with Brazil’s oncology centers and Mexico’s diagnostics.
Middle East & Africa: 7%–12% growth, with UAE’s healthcare tech and South Africa’s cancer programs.
Key Market Players and Competitive Landscape
Paige.AI: AI-driven diagnostics, $200M funding.
PathAI: Cancer detection algorithms, 15% YoY growth.
Proscia: Cloud-based WSI, 10% market share.
Ibex Medical Analytics: Breast cancer diagnostics leader.
Aiforia: EU-focused AI platforms.
Visiopharm: Image analysis software.
Akoya Biosciences: Biomarker discovery, $150M revenue.
Industry Value Chain AnalysisThe value chain spans algorithm development, imaging, and diagnostic integration.
Raw Materials and Upstream SupplyWSI scanners and cloud servers, with Paige.AI securing 1,000 units annually.
Production and ProcessingAI models process 10,000 slides daily, with PathAI scaling operations.
Distribution and LogisticsCloud delivery ensures 99% uptime.
Downstream Processing and Application Integration
Hospitals: AI diagnostics.
Biotech: Biomarker analysis.Downstream yields 25% margins via automation.
End-User IndustriesLabs capture value through 95% diagnostic accuracy.
Market Opportunities and Challenges
OpportunitiesAsia-Pacific’s cancer rise drives AI adoption. Europe’s digital labs boost growth, while Latin America’s oncology expands. Cloud and telepathology enhance scalability, and biomarker niches grow.
ChallengesHigh costs—$500K per system—limit adoption. Regulatory delays slow approvals by 12 months. Data privacy risks 10% trust erosion, while pathologist training gaps impact integration.
Table of Contents
80 Pages
- Chapter 1 Executive Summary
- Chapter 2 Abbreviation and Acronyms
- Chapter 3 Preface
- 3.1 Research Scope
- 3.2 Research Sources
- 3.2.1 Data Sources
- 3.2.2 Assumptions
- 3.3 Research Method
- Chapter Four Market Landscape
- 4.1 Market Overview
- 4.2 Classification/Types
- 4.3 Application/End Users
- Chapter 5 Market Trend Analysis
- 5.1 Introduction
- 5.2 Drivers
- 5.3 Restraints
- 5.4 Opportunities
- 5.5 Threats
- Chapter 6 Industry Chain Analysis
- 6.1 Upstream/Suppliers Analysis
- 6.2 Computational Pathology Analysis
- 6.2.1 Technology Analysis
- 6.2.2 Cost Analysis
- 6.2.3 Market Channel Analysis
- 6.3 Downstream Buyers/End Users
- Chapter 7 Latest Market Dynamics
- 7.1 Latest News
- 7.2 Merger and Acquisition
- 7.3 Planned/Future Project
- 7.4 Policy Dynamics
- Chapter 8 Historical and Forecast Computational Pathology Market in North America (2020-2030)
- 8.1 Computational Pathology Market Size
- 8.2 Computational Pathology Market by End Use
- 8.3 Competition by Players/Suppliers
- 8.4 Computational Pathology Market Size by Type
- 8.5 Key Countries Analysis
- 8.5.1 United States
- 8.5.2 Canada
- 8.5.3 Mexico
- Chapter 9 Historical and Forecast Computational Pathology Market in South America (2020-2030)
- 9.1 Computational Pathology Market Size
- 9.2 Computational Pathology Market by End Use
- 9.3 Competition by Players/Suppliers
- 9.4 Computational Pathology Market Size by Type
- 9.5 Key Countries Analysis
- 9.5.1 Brazil
- 9.5.2 Argentina
- 9.5.3 Chile
- 9.5.4 Peru
- Chapter 10 Historical and Forecast Computational Pathology Market in Asia & Pacific (2020-2030)
- 10.1 Computational Pathology Market Size
- 10.2 Computational Pathology Market by End Use
- 10.3 Competition by Players/Suppliers
- 10.4 Computational Pathology Market Size by Type
- 10.5 Key Countries Analysis
- 10.5.1 China
- 10.5.2 India
- 10.5.3 Japan
- 10.5.4 South Korea
- 10.5.5 Southest Asia
- 10.5.6 Australia
- Chapter 11 Historical and Forecast Computational Pathology Market in Europe (2020-2030)
- 11.1 Computational Pathology Market Size
- 11.2 Computational Pathology Market by End Use
- 11.3 Competition by Players/Suppliers
- 11.4 Computational Pathology Market Size by Type
- 11.5 Key Countries Analysis
- 11.5.1 Germany
- 11.5.2 France
- 11.5.3 United Kingdom
- 11.5.4 Italy
- 11.5.5 Spain
- 11.5.6 Belgium
- 11.5.7 Netherlands
- 11.5.8 Austria
- 11.5.9 Poland
- 11.5.10 Russia
- Chapter 12 Historical and Forecast Computational Pathology Market in MEA (2020-2030)
- 12.1 Computational Pathology Market Size
- 12.2 Computational Pathology Market by End Use
- 12.3 Competition by Players/Suppliers
- 12.4 Computational Pathology Market Size by Type
- 12.5 Key Countries Analysis
- 12.5.1 Egypt
- 12.5.2 Israel
- 12.5.3 South Africa
- 12.5.4 Gulf Cooperation Council Countries
- 12.5.5 Turkey
- Chapter 13 Summary For Global Computational Pathology Market (2020-2025)
- 13.1 Computational Pathology Market Size
- 13.2 Computational Pathology Market by End Use
- 13.3 Competition by Players/Suppliers
- 13.4 Computational Pathology Market Size by Type
- Chapter 14 Global Computational Pathology Market Forecast (2025-2030)
- 14.1 Computational Pathology Market Size Forecast
- 14.2 Computational Pathology Application Forecast
- 14.3 Competition by Players/Suppliers
- 14.4 Computational Pathology Type Forecast
- Chapter 15 Analysis of Global Key Vendors
- 15.1 Paige.AI
- 15.1.1 Company Profile
- 15.1.2 Main Business and Computational Pathology Information
- 15.1.3 SWOT Analysis of Paige.AI
- 15.1.4 Paige.AI Computational Pathology Revenue, Gross Margin and Market Share (2020-2025)
- 15.2 PathAI
- 15.2.1 Company Profile
- 15.2.2 Main Business and Computational Pathology Information
- 15.2.3 SWOT Analysis of PathAI
- 15.2.4 PathAI Computational Pathology Revenue, Gross Margin and Market Share (2020-2025)
- 15.3 Proscia
- 15.3.1 Company Profile
- 15.3.2 Main Business and Computational Pathology Information
- 15.3.3 SWOT Analysis of Proscia
- 15.3.4 Proscia Computational Pathology Revenue, Gross Margin and Market Share (2020-2025)
- 15.4 Ibex Medical Analytics
- 15.4.1 Company Profile
- 15.4.2 Main Business and Computational Pathology Information
- 15.4.3 SWOT Analysis of Ibex Medical Analytics
- 15.4.4 Ibex Medical Analytics Computational Pathology Revenue, Gross Margin and Market Share (2020-2025)
- Please ask for sample pages for full companies list
- Tables and Figures
- Table Abbreviation and Acronyms
- Table Research Scope of Computational Pathology Report
- Table Data Sources of Computational Pathology Report
- Table Major Assumptions of Computational Pathology Report
- Figure Market Size Estimated Method
- Figure Major Forecasting Factors
- Figure Computational Pathology Picture
- Table Computational Pathology Classification
- Table Computational Pathology Applications
- Table Drivers of Computational Pathology Market
- Table Restraints of Computational Pathology Market
- Table Opportunities of Computational Pathology Market
- Table Threats of Computational Pathology Market
- Table COVID-19 Impact for Computational Pathology Market
- Table Raw Materials Suppliers
- Table Different Production Methods of Computational Pathology
- Table Cost Structure Analysis of Computational Pathology
- Table Key End Users
- Table Latest News of Computational Pathology Market
- Table Merger and Acquisition
- Table Planned/Future Project of Computational Pathology Market
- Table Policy of Computational Pathology Market
- Table 2020-2030 North America Computational Pathology Market Size
- Figure 2020-2030 North America Computational Pathology Market Size and CAGR
- Table 2020-2030 North America Computational Pathology Market Size by Application
- Table 2020-2025 North America Computational Pathology Key Players Revenue
- Table 2020-2025 North America Computational Pathology Key Players Market Share
- Table 2020-2030 North America Computational Pathology Market Size by Type
- Table 2020-2030 United States Computational Pathology Market Size
- Table 2020-2030 Canada Computational Pathology Market Size
- Table 2020-2030 Mexico Computational Pathology Market Size
- Table 2020-2030 South America Computational Pathology Market Size
- Figure 2020-2030 South America Computational Pathology Market Size and CAGR
- Table 2020-2030 South America Computational Pathology Market Size by Application
- Table 2020-2025 South America Computational Pathology Key Players Revenue
- Table 2020-2025 South America Computational Pathology Key Players Market Share
- Table 2020-2030 South America Computational Pathology Market Size by Type
- Table 2020-2030 Brazil Computational Pathology Market Size
- Table 2020-2030 Argentina Computational Pathology Market Size
- Table 2020-2030 Chile Computational Pathology Market Size
- Table 2020-2030 Peru Computational Pathology Market Size
- Table 2020-2030 Asia & Pacific Computational Pathology Market Size
- Figure 2020-2030 Asia & Pacific Computational Pathology Market Size and CAGR
- Table 2020-2030 Asia & Pacific Computational Pathology Market Size by Application
- Table 2020-2025 Asia & Pacific Computational Pathology Key Players Revenue
- Table 2020-2025 Asia & Pacific Computational Pathology Key Players Market Share
- Table 2020-2030 Asia & Pacific Computational Pathology Market Size by Type
- Table 2020-2030 China Computational Pathology Market Size
- Table 2020-2030 India Computational Pathology Market Size
- Table 2020-2030 Japan Computational Pathology Market Size
- Table 2020-2030 South Korea Computational Pathology Market Size
- Table 2020-2030 Southeast Asia Computational Pathology Market Size
- Table 2020-2030 Australia Computational Pathology Market Size
- Table 2020-2030 Europe Computational Pathology Market Size
- Figure 2020-2030 Europe Computational Pathology Market Size and CAGR
- Table 2020-2030 Europe Computational Pathology Market Size by Application
- Table 2020-2025 Europe Computational Pathology Key Players Revenue
- Table 2020-2025 Europe Computational Pathology Key Players Market Share
- Table 2020-2030 Europe Computational Pathology Market Size by Type
- Table 2020-2030 Germany Computational Pathology Market Size
- Table 2020-2030 France Computational Pathology Market Size
- Table 2020-2030 United Kingdom Computational Pathology Market Size
- Table 2020-2030 Italy Computational Pathology Market Size
- Table 2020-2030 Spain Computational Pathology Market Size
- Table 2020-2030 Belgium Computational Pathology Market Size
- Table 2020-2030 Netherlands Computational Pathology Market Size
- Table 2020-2030 Austria Computational Pathology Market Size
- Table 2020-2030 Poland Computational Pathology Market Size
- Table 2020-2030 Russia Computational Pathology Market Size
- Table 2020-2030 MEA Computational Pathology Market Size
- Figure 2020-2030 MEA Computational Pathology Market Size and CAGR
- Table 2020-2030 MEA Computational Pathology Market Size by Application
- Table 2020-2025 MEA Computational Pathology Key Players Revenue
- Table 2020-2025 MEA Computational Pathology Key Players Market Share
- Table 2020-2030 MEA Computational Pathology Market Size by Type
- Table 2020-2030 Egypt Computational Pathology Market Size
- Table 2020-2030 Israel Computational Pathology Market Size
- Table 2020-2030 South Africa Computational Pathology Market Size
- Table 2020-2030 Gulf Cooperation Council Countries Computational Pathology Market Size
- Table 2020-2030 Turkey Computational Pathology Market Size
- Table 2020-2025 Global Computational Pathology Market Size by Region
- Table 2020-2025 Global Computational Pathology Market Size Share by Region
- Table 2020-2025 Global Computational Pathology Market Size by Application
- Table 2020-2025 Global Computational Pathology Market Share by Application
- Table 2020-2025 Global Computational Pathology Key Vendors Revenue
- Figure 2020-2025 Global Computational Pathology Market Size and Growth Rate
- Table 2020-2025 Global Computational Pathology Key Vendors Market Share
- Table 2020-2025 Global Computational Pathology Market Size by Type
- Table 2020-2025 Global Computational Pathology Market Share by Type
- Table 2025-2030 Global Computational Pathology Market Size by Region
- Table 2025-2030 Global Computational Pathology Market Size Share by Region
- Table 2025-2030 Global Computational Pathology Market Size by Application
- Table 2025-2030 Global Computational Pathology Market Share by Application
- Table 2025-2030 Global Computational Pathology Key Vendors Revenue
- Figure 2025-2030 Global Computational Pathology Market Size and Growth Rate
- Table 2025-2030 Global Computational Pathology Key Vendors Market Share
- Table 2025-2030 Global Computational Pathology Market Size by Type
- Table 2025-2030 Computational Pathology Global Market Share by Type
- Table Paige.AI Information
- Table SWOT Analysis of Paige.AI
- Table 2020-2025 Paige.AI Computational Pathology Revenue Gross Profit Margin
- Figure 2020-2025 Paige.AI Computational Pathology Revenue and Growth Rate
- Figure 2020-2025 Paige.AI Computational Pathology Market Share
- Table PathAI Information
- Table SWOT Analysis of PathAI
- Table 2020-2025 PathAI Computational Pathology Revenue Gross Profit Margin
- Figure 2020-2025 PathAI Computational Pathology Revenue and Growth Rate
- Figure 2020-2025 PathAI Computational Pathology Market Share
- Table Proscia Information
- Table SWOT Analysis of Proscia
- Table 2020-2025 Proscia Computational Pathology Revenue Gross Profit Margin
- Figure 2020-2025 Proscia Computational Pathology Revenue and Growth Rate
- Figure 2020-2025 Proscia Computational Pathology Market Share
- Table Ibex Medical Analytics Information
- Table SWOT Analysis of Ibex Medical Analytics
- Table 2020-2025 Ibex Medical Analytics Computational Pathology Revenue Gross Profit Margin
- Figure 2020-2025 Ibex Medical Analytics Computational Pathology Revenue and Growth Rate
- Figure 2020-2025 Ibex Medical Analytics Computational Pathology Market Share
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.